dc.contributorGrupo de Controle do Peso
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2021-06-25T10:24:54Z
dc.date.accessioned2022-12-19T22:11:43Z
dc.date.available2021-06-25T10:24:54Z
dc.date.available2022-12-19T22:11:43Z
dc.date.created2021-06-25T10:24:54Z
dc.date.issued2021-01-01
dc.identifierArchives of Endocrinology and Metabolism, v. 65, n. 1, p. 14-23, 2021.
dc.identifier2359-4292
dc.identifier2359-3997
dc.identifierhttp://hdl.handle.net/11449/205996
dc.identifier10.20945/2359-3997000000322
dc.identifier2-s2.0-85101997256
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5386593
dc.description.abstractIntermittent fasting (IF) is an increasingly popular method of weight loss, as an alternative to daily caloric restriction (DCR). Several forms of IF exist, such as alternate-day fasting or time-restricted feeding regimens. Some of its proponents claim several health benefits unrelated to caloric restriction or weight loss, which rely mainly on animal models. Although several studies published in the last few years confirm that IF can be a useful and safe therapeutical option for obesity and related disorders, no superiority to conventional caloric restriction diets have emerged. There are still several questions left answered. In this Review, we discuss some of the claims, unveiling myths, facts, and presumptions about several models of IF. The focus of this article is obesity, but there is a brief discussion of the potential benefits of IF on overall human health.
dc.languageeng
dc.relationArchives of Endocrinology and Metabolism
dc.sourceScopus
dc.subjectCircadian rhythm
dc.subjectDiets
dc.subjectInsulin resistance
dc.subjectIntermittent fasting
dc.subjectObesity
dc.subjectType 2 diabetes
dc.subjectWeight loss
dc.titleIntermittent fasting for obesity and related disorders: Unveiling myths, facts, and presumptions
dc.typeOtros


Este ítem pertenece a la siguiente institución